Search results
Found 9289 matches for
What can I do to help my OA now?
There are several treatments for osteoarthritis which can help the condition and improve pain.
Patient and Public Engagement
We believe in involving the public and those with osteoarthritis in our work, and publicising the activities and discoveries of the Centre. We do this in a number of ways:
What is OA?
Osteoarthritis is the most common form of arthritis, affecting 8 million people in the UK. It can affect different joints in the body, most commonly the hand, knee, hip and spine.
Molecular Pathogenesis of OA
By identifying what causes osteoarthritis at all levels - in our case, the cell - we are able to contribute to the development of novel drugs to target the condition.
Inflammatory Arthritis Microbiome Consortium
Bacteria and other microorganisms of the intestinal tract (collectively known as the gut microbiota) have fundamental roles in maintaining a healthy immune system. The ultimate goal of the Inflammatory Arthritis Microbiome Consortium (IAMC) is to manipulate the human microbiota for the treatment of inflammatory arthritis.
Arthritis Therapy Acceleration Programme
The Arthritis Therapy Acceleration Programme (A-TAP) creates a hub of expertise and infrastructure to support clinical inflammatory disease research to narrow the gap between bench and bedside.
Kennedy Trust for Rheumatology Research
The Kennedy Trust for Rheumatology Research supports world-class research in rheumatology.
Centre for OA Pathogenesis Versus Arthritis
Established in 2013, the Centre for Osteoarthritis Pathogenesis funded by Versus Arthritis aims to develop new treatments for this disabling condition, improving healthcare and transforming people's lives.
The Building
As part of its relocation to Oxford the Kennedy Institute moved to a new £34 million purpose-built building located on the University Old Road Campus in 2013.
Translational Research
Our goal is to identify the molecular underpinnings of disease and apply this knowledge for the discovery of new drug targets or approaches for patient stratification.
Our History
The Kennedy Institute of Rheumatology has a rich history of research into inflammatory and musculoskeletal conditions and is world renowned for its pioneering work on anti-TNF therapy.
Accessibility
Website Accessibility Statement
Scientific Advisory Board
The Kennedy Institute is fortunate to have the support of an independent external advisory board comprised of experts in research fields relevant to its work. The Board meets fully every 2 years to review the activities, policies and future plans of the Institute and recommend further courses of action to strengthen the Institute.
Computational Biology
The Kennedy Institute's Genomics High Performance Compute Facility (KGen) provides outstanding infrastructure to support the application of high-throughput technologies to study the mechanisms of inflammatory and degenerative disease.